15:32:14 EDT Mon 25 Jun 2018
Enter Symbol
or Name

Symbol U : ONTY
Recent Sedar Documents

Oncothyreon to Present at Cowen and Company 33rd Annual Health Care Conference

2013-02-27 08:00 ET - News Release

SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Cowen and Company 33rd Annual Health Care Conference in Boston on Wednesday, March 6, 2013 at 8 a.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

© 2018 Canjex Publishing Ltd. All rights reserved.